Interesting new thread @kpax
It may be time to begin considering a trade name for Monepantel going forward with our regulatory approvals.
PAA hold the patent and therefore have the right to select the name.
For what it's worth, I have a serious suggestion:
Sasquonab
It fits the drug brand naming conventions. It is not to be confused with any other drugs or medical trade names. It is relatively short and easily pronounced.
egoctor's advice : "Take two Sasquonabs and see me in the morning".
"
Pharmaust brand name required, page-5
-
- There are more pages in this discussion • 26 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
17.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $85.12M | |||
| Open | High | Low | Value | Volume |
| 18.0¢ | 18.0¢ | 17.0¢ | $141.2K | 801.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 537419 | 17.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.0¢ | 140000 | 3 |
View Market Depth
| Last trade - 16.10pm 06/09/2024 (20 minute delay) ? |
| PAA (ASX) Chart |